Research Article
Three-Year Point Prevalence Survey of Antimicrobial Use in a Chinese University Hospital
Table 1
Demographics and clinical characteristics of inpatients for the 3 years of PPSs.
| | Year | 2018-Oct | 2019-Nov | 2020-Nov | Grand total | value |
| | Sex, male, N (%) | 225 (55.0) | 86 (73.5) | 115 (59.3) | 426 (59.2) | | | Number of patients, N | 409 | 117 | 194 | 720 | | | Bed occupancy rate in total, (%) | 95.6 | 88.6 | 88.9 | 91 | | | Age, median, (IQR) | 62 (26–85) | 61 (28–78) | 62 (31–88) | 62 (26–88) | |
| | Patients with devices in place, N (%) | | | CVC/CV port/PICC | 15 (3.7) | 7 (5.9) | 2 (1.0) | 24 (3.3) | 0.053 | | PVC | 38 (9.3) | 26 (22.2) | 9 (4.6) | 73 (10.1) | <0.001 | | Urinary catheter | 45 (11.0) | 14 (12.0) | 16 (8.2) | 75 (10.4) | 0.489 | | Tracheal-tracheostomy tube | 21 (5.1) | 4 (3.4) | 4 (2.1) | 29 (4.0) | 0.188 | | Number of prescriptions, N | 196 | 79 | 46 | 321 | | | Targeted therapy, N (%) | 15 (7.7) | 10 (12.7) | 19 (41.3) | 44 (13.7) | <0.001 | | Treatment based on biomarker data, N (%) | 33 (16.8) | 18 (22.8) | 27 (58.7) | 78 (24.3) | <0.001 |
| | Surgical antibiotic prophylaxis | | Antimicrobials for surgical prophylaxis, N (%) | 27 (13.8) | 15 (19.0) | 10 (21.7) | 52 (16.2) | 0.310 | | Antimicrobials for surgical prophylaxis of ≤1 day, N (%) | 8 (29.6) | 5 (33.3) | 4 (40.0) | 17 (32.7) | 0.835 | | Surgical prophylaxis (single dose), N (%) | 23 (85.2) | 6 (40.0) | 5 (50.0) | 34 (65.4) | 0.007 | | Guideline compliance, N (%) | 25 (92.6) | 12 (80.0) | 8 (80.0) | 45 (86.5) | 0.413 |
|
|
CV, central venous; CVC, central venous catheter; PICC, peripherally inserted central catheter; PVC, peripheral venous catheter; IQR, interquartile range.
|
